BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10321608)

  • 1. Making sense of antigens and antibodies in pemphigus.
    Anhalt GJ
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):763-6. PubMed ID: 10321608
    [No Abstract]   [Full Text] [Related]  

  • 2. Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies.
    Kazerounian S; Mahoney MG; Uitto J; Aho S
    J Invest Dermatol; 2000 Sep; 115(3):505-7. PubMed ID: 10951291
    [No Abstract]   [Full Text] [Related]  

  • 3. [Auto-immune bullous diseases autoantibodies (pemphigus, bullous pemphigoid): what the dermatologist must know].
    Ingen-Housz-Oro S; Hüe S; Grootenboer-Mignot S; André C
    Ann Dermatol Venereol; 2013; 140(8-9):563-70. PubMed ID: 24034645
    [No Abstract]   [Full Text] [Related]  

  • 4. Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus.
    de Bruin A; Müller E; Wyder M; Anhalt GJ; Lemmens P; Suter MM
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):682-5. PubMed ID: 10321593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
    Nguyen VT; Ndoye A; Bassler KD; Shultz LD; Shields MC; Ruben BS; Webber RJ; Pittelkow MR; Lynch PJ; Grando SA
    Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune bullous skin diseases].
    Joly P
    Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex.
    Kiyokawa C; Ruhrberg C; Nie Z; Karashima T; Mori O; Nishikawa T; Green KJ; Anhalt GJ; DiColandrea T; Watt FM; Hashimoto T
    J Invest Dermatol; 1998 Dec; 111(6):1236-8. PubMed ID: 9856851
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins.
    Hashimoto T; Amagai M; Watanabe K; Dmochowski M; Chidgey MA; Yue KK; Garrod DR; Nishikawa T
    J Invest Dermatol; 1995 Apr; 104(4):541-4. PubMed ID: 7706774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
    Mimouni D; Foedinger D; Kouba DJ; Orlow SJ; Rappersberger K; Sciubba JJ; Nikolskaia OV; Cohen BA; Anhalt GJ; Nousari CH
    J Am Acad Dermatol; 2004 Jul; 51(1):62-7. PubMed ID: 15243525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus vulgaris with autoantibodies to desmoplakin.
    Kim SC; Chung YL; Kim J; Cho NJ; Amagai M
    Br J Dermatol; 2001 Nov; 145(5):838-40. PubMed ID: 11736914
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of pemphigus and desmosomal antigen expression by keratinocyte differentiation.
    Iwatsuki K; Harada H; Zhang JZ; Maruyama K; Kaneko F
    Dermatology; 1994; 189 Suppl 1():67-71. PubMed ID: 8049568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
    Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
    Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris.
    Joly P; Thomine E; Gilbert D; Verdier S; Delpech A; Prost C; Lebbe C; Lauret P; Tron F
    J Invest Dermatol; 1994 Jul; 103(1):65-72. PubMed ID: 8027582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Developments on paraneoplasic pemphigus].
    Caneppèle-Carel S; Mazereeuw-Hautier J; Bazex J
    Ann Dermatol Venereol; 2001 Apr; 128(4):561-6. PubMed ID: 11395661
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of paraneoplastic pemphigus with antidesmoglein 1 antibodies as determined by immunoblotting.
    Martel P; Gilbert D; Labeille B; Kanitakis J; Joly P
    Br J Dermatol; 2000 Apr; 142(4):812-3. PubMed ID: 10792239
    [No Abstract]   [Full Text] [Related]  

  • 16. Desmosome-binding antibody KM48 recognises an extracellular antigen different from desmosomal cadherins Dsg 1-3 and Dsc 1-3.
    Duhieu S; Laperdrix C; Hashimoto T; Le Bitoux MA; Haftek M
    Eur J Dermatol; 2005; 15(2):80-4. PubMed ID: 15757816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.
    Zhang B; Zheng R; Wang J; Bu D; Zhu X
    J Invest Dermatol; 2006 Apr; 126(4):832-40. PubMed ID: 16470171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies.
    Inaoki M; Kodera M; Fujimoto A; Nousari HC; Anhalt GJ; Takehara K
    Br J Dermatol; 2001 Mar; 144(3):610-3. PubMed ID: 11260026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac autoantibodies from patients affected by a new variant of endemic pemphigus foliaceus in Colombia, South America.
    Abreu-Velez AM; Howard MS; Jiao Z; Gao W; Yi H; Grossniklaus HE; Duque-Ramírez M; Dudley SC
    J Clin Immunol; 2011 Dec; 31(6):985-97. PubMed ID: 21796504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.